Adial Pharmaceuticals

12/09/2022

According to the National Institute on Alcohol Abuse and Alcoholism, an estimated 95,000 people (approximately 68,000 men and 27,000 women) die from alcohol-related causes annually, making alcohol the third-leading preventable cause of death in the US. Learn about the prevalence of alcohol use disorder:

According to the 2017 National Survey on Drug Use and Health (NSDUH), 86.3 percent of people ages 18 or older reported that they drank alcohol at some point in their lifetime; 70.1 percent reported that they drank in the past year; 55.9 percent reported that they drank in the past month.

09/09/2022

- Purnovate achieved positive in-vivo data from its study with mice treated with Purnovate’s PNV-6005 as a potential treatment for . Learn more about the study: https://bit.ly/3ATLdyd $ADIL

September 6, 2022 PDF Adial Pharmaceuticals Announces Positive In-Vivo Non-clinical Data with Purnovate’s PNV-6005 as a Potential Treatment for Ulcerative Colitis PNV-6005 significantly reduced both weight loss and colon damage in ulcerative colitis animal model CHARLOTTESVILLE, Va., Sept. 06, 202...

08/09/2022

What is the difference between binge drinking and alcohol use disorder? Healthline defines the two patterns of alcohol use and outlines the risk factors for each:

Both binge drinking and alcohol use disorder can have health consequences. Learn the difference between the two, plus how to get support.

07/09/2022

Adial's CEO Cary Claiborne comments on the potential of the Purnovate platform's potential following positive in-vivo non-clinical data with Purnovate’s PNV-6005 as a potential treatment for ulcerative colitis: https://bit.ly/3ATLdyd

06/09/2022

Adial today announced that Purnovate, Inc. achieved positive in-vivo data from its study with mice treated with Purnovate’s PNV-6005 as a potential treatment for inflammatory bowel diseases. In the study, PNV-6005 significantly reduced both weight loss and colon damage in the ulcerative colitis animal model. The positive results follow a recent research collaboration agreement between Purnovate and UC San Diego to evaluate the Company’s proprietary adenosine analogs as a potential treatment for inflammatory diseases, including IBD and infectious diseases where a large immune response plays a significant role. For details: https://bit.ly/3ATLdyd

01/09/2022

Drinking alone during adolescence and young adulthood strongly increases the risk for alcohol use disorder (AUD) later in life, especially high for women, which can cause serious health consequences in the future, both mentally and physically. For more:

A new study has found that drinking alone during adolescence and young adulthood strongly increases risk for alcohol use disorder (AUD) later in life. This risk is especially high for women.

31/08/2022

According to a new study, perfectionist traits—higher self-criticism, and unrealistic standards leading to isolation—are associated with severe alcohol use disorder (AUD). Learn more:

New research suggests that perfectionism may increase a person’s vulnerability to severe alcohol use disorder. But other personality traits and mental health conditions may also be risk factors for excessive alcohol consumption.

30/08/2022

What do the current U.S. Dietary Guidelines say about alcohol consumption? Learn about the guidelines and why some should avoid alcohol altogether from the NIAAA:

Those who drink within the low risk limits are less likely to have alcoholism or alcohol abuse. Are you within these low-risk levels?

24/08/2022

Mr. Cary Claiborne, newly appointed Adial CEO, comments on the Company's plans to discuss the ONWARD™ results with both European and U.S. regulatory agencies. For more: https://bit.ly/3wjqRwP

23/08/2022

Adial will host a conference call today, August 23rd at 8:30am EDT. To tune-in, please dial 888-506-0062 (U.S) or 973-528-0011 (international) and enter access code 321005, or access a webcast here: https://bit.ly/3wpMZGa

22/08/2022

Adial announced the appointment of Cary J. Claiborne as President and Chief Executive Officer. Mr. Claiborne, who has 18 years of experience in leadership roles with clinical and commercial stage, publicly traded biopharmaceutical companies, takes over the role of William Stilley, who was appointed to the newly created position of CEO of Purnovate, Inc. Both executives will remain on the Board of Directors of Adial. The Company will host a conference call tomorrow, August 23rd at 8:30am EDT. For details: https://bit.ly/3wjqRwP

18/08/2022

A study from Carnegie Mellon University suggests that drinking alone during adolescence and young adulthood strongly increases the risk for alcohol use disorder (AUD) later in life. Women tend to have a higher risk of AUD than men. For more:

A new study has found that drinking alone as an adolescent and young adult can increase the risk of alcohol use disorder later in life, especially for women.